Home / Health / Cabinet Sub-committee Approves 52 Life-Saving Drug Prices
Cabinet Sub-committee Approves 52 Life-Saving Drug Prices
26 Jul
Summary
- Sub-committee approved prices for 52 life-saving drugs.
- Approval is pending final federal cabinet review.
- New prices cover cancer, diabetes drugs, and vaccines.
A sub-committee of Pakistan's federal cabinet has greenlit the pricing for 52 essential life-saving drugs. This crucial decision, made on July 26, 2026, is now awaiting the final approval of the federal cabinet.
Health Minister Mustafa Kamal expressed optimism, stating that this move will enable patients to access cheaper, high-quality medications. He clarified that the approved medicines were categorized under price fixation, including new drugs and alternatives for existing treatments.
The approved list encompasses vital medications for conditions such as cancer and diabetes, along with essential vaccines. Once the federal cabinet provides its endorsement, production is expected to commence, making these critical medicines readily available to consumers across the country.
